• Kinnos

  Led · Seed · Mar 2017

  Kinnos's core product, Highlight, is a patented, hospital-grade color additive platform that temporarily colors disinfectant wipes and solutions to provide staff with an instantaneous visual cue to improve disinfection quality. Highlight is Star Registered by the Global Biorisk Advisory Council and recognized by the World Health Organization; a peer-reviewed study in the American Journal of Infection Prevention found it improved disinfection quality by as much as 70%. Highlight is already in use by hospitals, first responders, and transit agencies around the world and the company positions the product as a way to raise the standard of care for cleanliness and infection prevention. Kinnos was founded in 2015 during the Ebola outbreak and is headquartered in Brooklyn, NY. The company announced a $15 million financing to meet growing healthcare industry demand and to scale commercial deployment. It also named healthcare veteran Steve Fanning as CEO to lead rapid growth and commercialization. Kinnos is a New York–based startup that makes colorized disinfectant additives to ensure surfaces are covered. Its core products are Highlight powder, a patented additive dissolved into bulk bleach that colors solutions blue and fades after a few minutes, and Highlight wipes, which impregnate wipes at point of use. The company primarily targets hospitals and healthcare settings and has sold to humanitarian organizations deployed to Liberia, Guinea, Haiti, DR Congo and Uganda, with recent shipments to China amid the coronavirus outbreak. Kinnos is a five-person company founded six years ago and conducts third‑party testing to ensure its additive does not reduce disinfectant potency. The additive lasts about five hours in a bucket of bleach and fades on surfaces in about three minutes. After establishing a foothold in hospitals, the company is considering a consumer offering. Kinnos developed Highlight, a patent-pending additive for disinfectants designed to improve visibility, coverage, and end-user compliance. The product was created in response to the Ebola crisis in West Africa and has been field-tested in Liberia, Guinea, and Haiti. Highlight is used by the Fire Department of New York and Kinnos was a grantee of the USAID Fighting Ebola Grand Challenge. The company has received recognition including the Lemelson-MIT Student Prize, Collegiate Inventors Competition, and Columbia Venture Competition, and has been featured in the Wall Street Journal, Scientific American, and Forbes 30 Under 30 in Healthcare. Kinnos is led by CEO Jason Kang. Financially, Kinnos recently closed a $1M seed round led by Georgica Advisors with participation from New York Angels, VentureWell, and other strategic angel investors.

No current team members are available.